Science Explorer Back to mapMap
Discussion
Institution · Adelphi Group (United Kingdom)

Most cited papers from Adelphi Group (United Kingdom)

Adelphi Group (United Kingdom)

What are the most cited papers from Adelphi Group (United Kingdom)?

The most cited paper from Adelphi Group (United Kingdom) is "Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand" (Peter E. Anderson, Mike Benford, Nancy L. Harris et al., 2008), with 529 citations. Next come "Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial" (434) and "Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes" (409).

Showing 50 of 60 papers. Every paper with more than 96 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand Peter E. Anderson, Mike Benford, Nancy L. Harris et al. · Current Medical Research and Opinion 30 Sep 2008 529
2 Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial Kevin Joseph Harrington et al. · The Lancet Oncology Open access 24 Jun 2017 434
3 Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes Omar Sharif Usmani, Federico Lavorini, Jonathan Marshall et al. · Respiratory Research ReviewOpen access 16 Jan 2018 409
4 International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium Corneel Coens et al. · The Lancet Oncology Open access 30 Jan 2020 323
5 The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey Mike D. Thomas, Stephen Kay, James Pike et al. · Primary Care Respiratory Journal Open access 24 Feb 2009 304
6 A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective Peter Charles Taylor, Adam Moore, Radu Vasilescu et al. · Rheumatology International Open access 8 Jan 2016 302
7 Evaluating the quality of life of patients with restless legs syndrome Linda N. Abetz, Richard P. Allen, Alain Follet et al. · Clinical Therapeutics Jun 2004 299
8 Immunogenicity and protective efficacy of influenza vaccination CLAUDE HANNOUN, Francoise Megas, James Piercy · Virus Research 29 May 2004 264
9 Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015 Victoria Higgins, James Piercy, Adam Roughley et al. · Diabetes Metabolic Syndrome and Obesity Open access Nov 2016 263
10 Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme S.M. Babineaux, B. Curtis, Tim Holbrook et al. · BMJ Open Open access Aug 2016 255
11 The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study Shrividya S. Iyer, Adam Roughley, Alex Rider et al. · Supportive Care in Cancer 11 Sep 2013 229
12 Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes Mirko V. Sikirica, Alan A Martin, Robert P Wood et al. · Diabetes Metabolic Syndrome and Obesity Open access Sep 2017 223
13 Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial David F Cella, Viktor Grünwald, Paul Nathan et al. · The Lancet Oncology Open access 6 Jun 2016 221
14 Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial Martin Reck et al. · European Journal of Cancer Open access 11 Jun 2019 220
15 Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards Andrew Bottomley et al. · The Lancet Oncology 18 Oct 2016 204
16 Development and psychometric evaluation of the Discrimination and Stigma Scale (DISC) Elaine Brohan, Sarah Clement, Diana Susan Rose et al. · Psychiatry Research Open access 9 Apr 2013 203
17 Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey ( SWAY ) Ifeyinwa Osunkwo et al. · American Journal of Hematology Open access 2 Dec 2020 201
18 Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany Shrividya S. Iyer, Gavin Taylor‐Stokes, Adam Roughley · Lung Cancer 4 Apr 2013 200
19 Factors associated with treatment nonadherence among US bipolar disorder patients Ross J. Baldessarini, Richard A. Perry, James Pike · Human Psychopharmacology Clinical and Experimental 3 Dec 2007 199
20 The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence Richard A. Perry, George Braileanu, Thomas Palmer et al. · PharmacoEconomics Open access 13 Oct 2018 198
21 Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types Jammbe Z. Musoro, Corneel Coens, Mirjam A. G. Sprangers et al. · European Journal of Cancer Open access 7 May 2023 195
22 The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics Enno Christophers, JNWN Barker, CEM Griffiths et al. · Journal of the European Academy of Dermatology and Venereology 23 Oct 2009 192
23 Establishing the health and economic impact of influenza vaccination within the European Union 25 countries James Arthur Ryan, York F Zoellner, Birgit Gradl et al. · Vaccine 7 Aug 2006 182
24 Evaluation of Quality of Life and Priorities of Patients with Glaucoma Peter Aspinall, Zoë Johnson, Augusto Azuara‐Blanco et al. · Investigative Ophthalmology & Visual Science 24 Apr 2008 181
25 Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients Linda N. Abetz, Krithika Rajagopalan, Polyxane Mertzanis et al. · Health and Quality of Life Outcomes Open access 2011 180
26 Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer Kim Cocks, Jane R. Wells, Colin A. Johnson et al. · European Journal of Cancer Open access 31 Oct 2022 179
27 Interventions for treating anxiety after stroke Peter Knapp, Cassandra A. Burton, John Holmes et al. · Cochrane Database of Systematic Reviews Open access 23 May 2017 175
28 A systematic review of the evidence of the burden of bipolar disorder in Europe Liberty Fajutrao, Julie C. Locklear, Jennifer Priaulx et al. · Clinical Practice and Epidemiology in Mental Health ReviewOpen access 2009 158
29 A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH) Manca Povsic, On Yee Wong, Richard A. Perry et al. · Advances in Therapy Open access 7 May 2019 157
30 Preference and Relative Importance for Environmental Attributes of Neighbourhood Open Space in Older People Peter Aspinall, Catharine Ward Thompson, Susana Martins Alves et al. · Environment and Planning B Planning and Design 2010 149
31 Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD Henry Chrystyn, Mark A. Small, Gary W. Milligan et al. · Respiratory Medicine Open access 2 Oct 2013 147
32 The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey Claire N. Harrison, Steffen Koschmieder, Lynda M. Foltz et al. · Annals of Hematology Open access 5 Aug 2017 146
33 “Not Just Little Adults”: Qualitative Methods to Support the Development of Pediatric Patient-Reported Outcomes Rob Arbuckle, Linda Abetz‐Webb · Patient 2 Aug 2013 146
34 Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis Jörn Markus Schattenberg et al. · Liver International Open access 18 Feb 2021 145
35 Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes Peter E. Anderson, Victoria Higgins, Jonathan de Courcy et al. · Current Medical Research and Opinion Open access 7 Nov 2023 143
36 A Real‐World Analysis of Migraine: A Cross‐Sectional Study of Disease Burden and Treatment Patterns Janet H. Ford, James D. Jackson, Gary W. Milligan et al. · Headache The Journal of Head and Face Pain 6 Oct 2017 134
37 Quality of life and clinical correlates in patients with diabetic foot ulcers P. Valensi, Isabelle Girod, F Baron et al. · Diabetes & Metabolism Jun 2005 131
38 Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group Priti P. Pednekar, Tamás Ágh, Maria Malmenäs et al. · Value in Health ReviewOpen access 25 Oct 2018 128
39 Immune thrombocytopenia ( ITP ) World Impact Survey ( I‐WISh ): Impact of ITP on health‐related quality of life Nichola Cooper, Alexandra Kruse, Caroline Gentile Kruse et al. · American Journal of Hematology Open access 27 Oct 2020 127
40 High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review Jakob Langer, Verna L. Lamar Welch, Mary M. Moran et al. · Advances in Therapy ReviewOpen access 15 Feb 2023 122
41 Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance Laura Holloway, Louise Humphrey, Louise Heron et al. · Health and Quality of Life Outcomes Open access 21 Jul 2014 122
42 Validation of the Restless Legs Syndrome Quality of Life Questionnaire Linda N. Abetz, Susan Vallow, Jeff Kirsch et al. · Value in Health Open access Mar 2005 122
43 The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting Linda N. Abetz, Robert A. Arbuckle, Richard P. Allen et al. · Sleep Medicine 22 May 2006 121
44 Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer Jammbe Z. Musoro, Corneel Coens, Frédéric Fiteni et al. · JNCI Cancer Spectrum Open access 20 May 2019 116
45 Preferences of older people for environmental attributes of local parks Susana Martins Alves, Peter Aspinall, Catharine Ward Thompson et al. · Facilities 22 Aug 2008 116
46 Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study MIRIAD study group, Simone E. Farrelly, Sarah Clement et al. · BMC Psychiatry Open access 29 May 2014 111
47 Social and economic burden of walking and mobility problems in multiple sclerosis James Pike, Edward L. Jones, Krithika Rajagopalan et al. · BMC Neurology Open access 18 Sep 2012 110
48 Impact of night-time symptoms in COPD: a real-world study in five European countries David Price, Small, Gary W. Milligan et al. · International Journal of COPD Open access Nov 2013 110
49 Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment Nichola Cooper, Alexandra Kruse, Caroline Gentile Kruse et al. · American Journal of Hematology Open access 10 Nov 2020 109
50 Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data Heleen van Haalen, James D. Jackson, Bruce Spinowitz et al. · BMC Nephrology Open access 6 Mar 2020 108

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.